Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Article in German | MEDLINE | ID: mdl-33588460

ABSTRACT

OBJECTIVES: The aim of this study was to assess the distribution and frequency of uroliths in dogs in Germany and to evaluate age-, gender-, and breed-specific differences. MATERIAL AND METHODS: A total of 2772 uroliths from dogs in Germany that had been submitted from veterinary practices during the years 2017-2019 were analyzed by infrared spectroscopy. RESULTS: Uroliths were analyzed as follows: Struvite (44.7 %), calcium oxalate monohydrate (whewellite 24.5 %), cystine (15.2 %), ammonium urate (5.3 %), calcium oxalate dihydrate (weddellite 4.4 %), calcium phosphate (1.6 %), xanthine (1.2 %), whewellite/weddellite (11 %), brushite (0.4 %) and other substances (1.7 %). The dogs' median age (in years) with regards to the urolith type amounted to: struvite 8, calcium oxalate (whewellite and weddellite) 10, cystine 5, brushite 11, xanthine 6.5, and ammonium urate 6 years. Struvite uroliths were most common in intact females (83.8 %) and neutered females (80.8 %), while cystine uroliths (36.7 %) and calcium oxalates (35.7 % whewellite and weddellite) were most common in intact males. Calcium oxalate (50 %), struvite (17.3 %), and cystine uroliths (10.5 %) were found in male neutered dogs. The most frequent breeds with struvite uroliths were Pug (75.9 %), Labrador (73.1 %), Shih Tzu (62.2 %), Dachshund (50.4 %) and Maltese (36 %). Calcium oxalates were most frequently encountered in the breeds Miniature Schnauzer (54.8 %), Jack Russell Terrier (49.5 %), and Yorkshire Terrier (48.2 %). Cystine uroliths were most frequent in the breeds French Bulldog (47.2 %), Bulldogs (44.8 %), Chihuahua (44.1 %) and Dachshund (32.8 %). CONCLUSION AND CLINICAL RELEVANCE: Dogs from Germany displayed age-, gender- and breed-specific differences in the frequency of urine calculi occurrence. Knowledge of the frequent occurrence of the distinct uroliths in Germany as well as potential breed dispositions allow the veterinarian to implement an appropriate preventive treatment plan. This would involve a targeted monitoring program for the prevention and follow-up care of the patient in conjunction with the pet owner.


Subject(s)
Dog Diseases/epidemiology , Urolithiasis/veterinary , Age Factors , Animals , Breeding , Dogs , Female , Germany/epidemiology , Male , Sex Factors , Urolithiasis/classification , Urolithiasis/epidemiology
2.
J Sci Food Agric ; 98(8): 2925-2934, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29168179

ABSTRACT

BACKGROUND: The need for a convenience herbal iced tea product with reduced kilojoules merited investigation of the shelf-life of powder mixtures containing a green Cyclopia subternata Vogel (honeybush) extract with proven blood glucose-lowering activity and alternative sweetener mixture. RESULTS: Prior to long-term storage testing, the wettability of powder mixtures containing food ingredients and the compatibility of their components were confirmed using the static sessile drop method and isothermal microcalorimetry, respectively. The powders packed in semi-sealed containers remained stable during storage at 25 °C/60% relative humidity (RH) for 6 months, except for small losses of specific phenolic compounds, namely mangiferin, isomangiferin, 3-ß-d-glucopyranosyliriflophenone, vicenin-2 and 3',5'-di-ß-d-glucopyranosylphloretin, especially when both citric acid and ascorbic acid were present. These acids drastically increased the degradation of phenolic compounds under accelerated storage conditions (40 °C/75% RH). Accelerated storage also caused changes in the appearance of powders and the colour of the reconstituted beverage solutions. Increased moisture content and aw of the powders, as well as moisture released due to dehydration of citric acid monohydrate, contributed to these changes. CONCLUSION: A low-kilojoule honeybush iced tea powder mixture will retain its functional phenolic compounds and physicochemical properties during shelf-life storage at 25 °C for 6 months. © 2017 Society of Chemical Industry.


Subject(s)
Beverages/analysis , Cyclopia Plant/chemistry , Inulin/chemistry , Phenols/chemistry , Plant Extracts/chemistry , Capsules/chemistry , Food Storage , Humidity , Powders/chemistry
3.
Curr Drug Targets ; 15(5): 486-501, 2014 May.
Article in English | MEDLINE | ID: mdl-24597532

ABSTRACT

Natural polymers are continuously investigated for use in pharmaceutical and tissue engineering applications due to the renewability of their supply. Besides the conventional use of natural materials in dosage form design such as fillers, they are progressively investigated as functional excipients in specialised dosage forms. The hydrophilic nature of natural polymers together with their non-toxic and biodegradable properties make them useful in the design of modified release dosage forms. Matrix type tablets and beads made from natural gums and mucilages often exhibit sustained drug release through erosion in combination with swelling. Natural polymers are used to reach different pharmaceutical objectives, for instance, inulin and pectin are plant derived polymers that have suitable properties to produce colon-specific drug delivery. Alginate is an example of a natural polymer that has been used in the formulation of gastro-retentive dosage forms. Different cellulose derived polymers have been investigated as coating materials for dosage forms. Natural polymers can be chemically modified to produce molecules with specific properties and formation of co-polymers or polymer mixtures provide new opportunities to develop innovative drug delivery systems.


Subject(s)
Biocompatible Materials/chemistry , Biopolymers/chemistry , Drug Delivery Systems/methods , Plants/chemistry , Alginates , Biopharmaceutics , Chemistry, Pharmaceutical , Delayed-Action Preparations/chemistry , Drug Carriers/chemistry , Glucuronic Acid , Hexuronic Acids , Organ Specificity
4.
Int J Pharm ; 449(1-2): 18-27, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23578825

ABSTRACT

The objective of this study was to describe the solid-state forms in which roxithromycin may exist and the significant influence of solution-mediated phase transformation on the dissolution and solubility behavior of these forms. Roxithromycin may exist as: Form I (monohydrate), Form II (amorphous), Form III (anhydrate) and a mixture of Forms I and III. Form III and Mixture I/III have not been reported previously, probably due to incomplete solid-state characterization or the use of a standard production method which consistently yielded the same solid-state form. Solution-mediated phase transformations of Forms II and III to the stable Form I were proved through dissolution studies and quantification of the phase proportions, as a function of time, utilizing XRPD. This study showed that pharmacopoeial identification methods for roxithromycin do not allow accurate identification of the different solid-state forms. The various forms differed significantly in terms of dissolution profiles, which could have a marked influence on bioavailability and performance of the final dosage form. It was demonstrated that solvent replacement, during dissolution testing, masks the characteristic profile usually obtained with a metastable form undergoing solution-mediated transformation. Finally, we propose that peak dissolution concentrations should be used to give a more exact indication of the aqueous solubility enhancement ratio obtained with metastable forms of APIs.


Subject(s)
Roxithromycin/chemistry , Thermodynamics , Chemistry, Pharmaceutical , Phase Transition , Solubility , Time Factors , X-Ray Diffraction
5.
J Physiol ; 590(14): 3317-33, 2012 Jul 15.
Article in English | MEDLINE | ID: mdl-22586225

ABSTRACT

Duodenocyte pHi control and HCO3 − secretion protects the proximal duodenum against damage by gastric acid. The molecular details of duodenocyte pH control are not well understood. A selective duodenal expression (within the upper GI tract) has been reported for the electroneutral Na+:HCO3 − cotransporter NBCn1 (Slc4a7). We aimed to determine the role of NBCn1 and NBCe2 in duodenocyte intracellular pH regulation as well as basal and agonist-stimulated duodenal bicarbonate secretion (JHCO3 −), exploiting mouse models of genetic slc4a7 and slc4a5 disruption. Basal and forskolin (FSK)-stimulated JHCO3 − was measured by single-pass perfusion in the duodenum of slc4a7−/− and slc4a7+/+ as well as slc4a5−/− and slc4a5+/+ mice in vivo, and by pH-stat titration in isolated duodenal mucosa in vitro. Duodenocyte HCO3 − uptake rates were fluorometrically assessed after acidification of intact villi and of isolated duodenocytes. Slc4a7−/− mice displayed significantly lower basal and FSK-stimulated duodenal HCO3 − secretion than slc4a7+/+ littermates in vivo. FSK-stimulated HCO3 − secretion was significantly reduced in slc4a7−/− isolated duodenal mucosa. Na+- and HCO3 −-dependent base uptake rates were significantly decreased in slc4a7−/− compared with slc4a7+/+ villus duodenocytes when measured in intact villi. Carbonic anhydrase (CA)-mediated CO2 hydration played no apparent role as a HCO3 − supply mechanism for basal or FSK-stimulated secretion in the slc4a7+/+ duodenum, but was an important alternative HCO3 − supply mechanism in the slc4a7−/− duodenum. NBCe2 (Slc4a5) displayed markedly lower duodenal mRNA expression levels, and its disruption did not interfere with duodenal HCO3 − secretion. The electroneutral Na+:HCO3 − cotransporter NBCn1 (slc4a7) is a major duodenal HCO3 − importer that supplies HCO3 − during basal and FSK-stimulated HCO3 − secretion.


Subject(s)
Bicarbonates/metabolism , Duodenum/metabolism , Intestinal Mucosa/metabolism , Sodium-Bicarbonate Symporters/metabolism , Animals , Carbon Dioxide/metabolism , Carbonic Anhydrases/metabolism , Colforsin/pharmacology , Hydrogen-Ion Concentration , Intestinal Mucosa/drug effects , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/biosynthesis , Sodium/metabolism , Sodium-Bicarbonate Symporters/genetics
6.
Metabolism ; 61(8): 1073-86, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22365040

ABSTRACT

Diabetic nephropathy is the most common cause of chronic renal failure in industrialized countries. Depletion of podocytes plays an important role in the progression of diabetic glomerulopathy. Various factors in the diabetic milieu lead to serious podocyte stress driving the cells toward cell cycle arrest (p27(Kip1)), hypertrophy, detachment, and apoptosis. Mitochondria are responsible for oxidative phosphorylation and energy supply in podocytes. Recent studies indicated that mitochondrial dysfunction is a key factor in diabetic nephropathy. In the present study, we investigated metabolic profiles of podocytes under diabetic conditions. We examined oxygen consumption rates (OCRs) and oxidative phosphorylation complex activities in murine podocytes. Cells were exposed to high glucose for 48 hours, cultured for 10 passages under high-glucose conditions (30 mmol/L), or incubated with transforming growth factor-ß (5 ng/mL) for 24 hours. After prolonged exposure to high glucose, podocytes showed a significantly increased OCR at baseline and also a higher OCR after addition of oligomycin, indicating significant changes in mitochondrial energy metabolism. Higher OCRs after inhibition of respiration by rotenone also indicated changes in nonmitochondrial respiration. Podocytes stimulated with a proapoptotic concentration of transforming growth factor-ß displayed similar bioenergetic profiles, even with decreased citrate synthase activity. In all tested conditions, we found a higher cellular nicotinamide adenine dinucleotide content and changes in activities of respiratory chain complexes. In summary, we provide for the first time evidence that key factors of the diabetic milieu induce changes in glucose metabolism and mitochondrial function in podocytes.


Subject(s)
Blood Glucose/metabolism , Diabetic Nephropathies/metabolism , Hyperglycemia/metabolism , Kidney Glomerulus , Mitochondria/metabolism , Oxygen Consumption , Podocytes/metabolism , Transforming Growth Factor beta/metabolism , Animals , Cells, Cultured , Diabetes Mellitus, Experimental , Diabetic Nephropathies/pathology , Diabetic Nephropathies/physiopathology , Fluorometry/methods , Glomerular Basement Membrane/drug effects , Glomerular Basement Membrane/metabolism , Glomerular Filtration Barrier/drug effects , Glucose Transporter Type 1/metabolism , Hyperglycemia/etiology , Immunohistochemistry , Indicators and Reagents , Kidney Glomerulus/drug effects , Kidney Glomerulus/metabolism , Kidney Glomerulus/pathology , Kidney Glomerulus/physiopathology , Male , Mice , Mice, Inbred Strains , Mitochondria/enzymology , Oxazines , Oxidation-Reduction , Phosphorylation , Podocytes/drug effects , Podocytes/enzymology , Podocytes/pathology , Reactive Oxygen Species/metabolism , Succinate Cytochrome c Oxidoreductase/metabolism , Succinate Dehydrogenase/metabolism , Xanthenes
8.
Diabetes Metab Res Rev ; 27(3): 207-15, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21309047

ABSTRACT

SUMMARY: Podocyte loss is a common feature in human diabetes as well as in experimental diabetes in rodents. Almost all components of the diabetic milieu lead to serious podocyte stress, driving the cells towards cell cycle arrest and hypertrophy, detachment and apoptosis. Common pathway components induced by high glucose and advanced glycation end-products are reactive oxygen species, cyclin-dependent kinases (p27(Kip1)) and transforming growth factor-beta. In addition, mechanical stresses by stretch or shear forces, insulin deficiency or insulin resistance are independent components resulting in podocyte apoptosis and detachment. In this review, we discuss the common pathways leading to podocyte death as well as novel pathways and concepts of podocyte dedifferentiation and detachment that influence the progression of diabetic glomerulopathy.


Subject(s)
Diabetes Mellitus, Type 1/pathology , Diabetes Mellitus, Type 2/pathology , Podocytes/pathology , Actins/physiology , Apoptosis , Chemokines/physiology , Cyclin-Dependent Kinase Inhibitor p27/metabolism , Cytokines/physiology , Diabetic Nephropathies/physiopathology , Glucose/metabolism , Glycation End Products, Advanced/metabolism , Humans , Hyperglycemia/physiopathology , Insulin/physiology , Insulin Resistance , Podocytes/metabolism , Stress, Mechanical , Transforming Growth Factor beta/metabolism
9.
Am J Physiol Gastrointest Liver Physiol ; 297(6): G1223-31, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19779011

ABSTRACT

A Na(+)/HCO(3)(-) cotransporter (NBC) is located in the basolateral membrane of the gastrointestinal epithelium, where it imports HCO(3)(-) during stimulated anion secretion. Having previously demonstrated secretagogue activation of NBC in murine colonic crypts, we now asked whether vesicle traffic and exocytosis are involved in this process. Electrogenic NBCe1-B was expressed at significantly higher levels than electroneutral NBCn1 in colonic crypts as determined by QRT-PCR. In cell surface biotinylation experiments, a time-dependent increase in biotinylated NBCe1 was observed, which occurred with a peak of +54.8% after 20 min with forskolin (P < 0.05) and more rapidly with a peak of +59.8% after 10 min with carbachol (P < 0.05) and which corresponded well with the time course of secretagogue-stimulated colonic bicarbonate secretion in Ussing chamber experiments. Accordingly, in isolated colonic crypts pretreated with forskolin and carbachol for 10 min, respectively, and subjected to immunohistochemistry, the NBCe1 signal showed a markedly stronger colocalization with the E-cadherin signal, which was used as a membrane marker, compared with the untreated control. Cytochalasin D did not change the observed increase in membrane abundance, whereas colchicine alone enhanced NBCe1 membrane expression without an additional increase after carbachol or forskolin, and LY294002 had a marked inhibitory effect. Taken together, our results demonstrate a secretagogue-induced increase of NBCe1 membrane expression. Vesicle traffic and exocytosis might thus represent a novel mechanism of intestinal NBC activation by secretagogues.


Subject(s)
Bicarbonates/metabolism , Cell Membrane/drug effects , Colon/drug effects , Gastrointestinal Agents/pharmacology , Intestinal Mucosa/drug effects , Intestinal Secretions/drug effects , Sodium-Bicarbonate Symporters/metabolism , Sodium/metabolism , Adenylyl Cyclases/metabolism , Animals , Biotinylation , Cadherins/metabolism , Carbachol/pharmacology , Cell Membrane/metabolism , Cholinergic Agonists/pharmacology , Colchicine/pharmacology , Colforsin/pharmacology , Colon/metabolism , Cyclic AMP/metabolism , Cytophotometry , Dose-Response Relationship, Drug , Enzyme Activators/pharmacology , Exocytosis/drug effects , Hydrogen-Ion Concentration , Immunohistochemistry , Intestinal Mucosa/metabolism , Membrane Potentials , Mice , Mice, Inbred C57BL , Mice, Knockout , Polymerase Chain Reaction , Secretory Vesicles/drug effects , Secretory Vesicles/metabolism , Sodium-Bicarbonate Symporters/deficiency , Sodium-Bicarbonate Symporters/genetics , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...